| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.097 | 0.008 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.093 | 0.009 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.085 | 0.009 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.095 | 0.009 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.009 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.01 |